Current Liabilities decreased faster than Legacy Ventures International Inc's Cash & cash equivalent, this led to improvement in Legacy Ventures International Inc's Quick Ratio to 0.06, Quick Ratio remained below Legacy Ventures International Inc average.

Within Medical Equipment & Supplies industry 193 other companies have achieved higher Quick Ratio than Legacy Ventures International Inc in second quarter 2024. While Quick Ratio total ranking has improved so far during the Q2 2024 to 3960, from total ranking in the first quarter 2024 at 4120.

Explain Quick Ratio?
How much Cash & cash equivalents LGYV�s has?
What are LGYV�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LGYV Quick Ratio	(Dec 31 2024) Q2	(Sep 30 2024) Q1	(Jun 30 2024) Q4	(Mar 31 2024) Q3	(Dec 31 2023) Q2
Y / Y Current Liabilities Change	10.65 %	13.67 %	-14.03 %	16.58 %	14.94 %
Y / Y Cash & cash equivalent Change	16.75 %	29.69 %	-49.82 %	-58.73 %	136.52 %
Quick Ratio MRQ	0.06	0.03	0.03	0.04	0.06
LGYV's Total Ranking	# 3960	# 4120	# 4013	# 3610	# 3486
Seq. Current Liabilities Change	-61.54 %	21.63 %	59.22 %	48.55 %	-60.49 %
Seq. Cash & cash equivalent Change	-9.98 %	29.69 %	0 %	0 %	0 %

Quick Ratio second quarter 2024 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 194
Healthcare Sector	# 913
Overall Market	# 3960

Quick Ratio Statistics
High	Average	Low
1.04	0.11	0
(Jun 30 2022)		(Jun 30 2018)

Financial Statements
Legacy Ventures International Inc's Current Liabilities	$ 0 Millions	Visit LGYV's Balance sheet
Legacy Ventures International Inc's Cash & cash equivalent	$ 0 Millions	Visit LGYV's Balance sheet
Source of LGYV's Sales		Visit LGYV's Sales by Geography

Cumulative Legacy Ventures International Inc's Quick Ratio

LGYV's Quick Ratio for the trailling 12 Months

LGYV Quick Ratio	(Dec 31 2024) 12 Months	(Sep 30 2024) 12 Months	(Jun 30 2024) 12 Months	(Mar 31 2024) 12 Months	(Dec 31 2023) 12 Months
Y / Y Current Liabilities TTM Growth	3.68 %	4.06 %	26.02 %	70.74 %	-27.57 %
Y / Y Cash & cash equivalent TTM Growth	-30.41 %	-26.4 %	-60.52 %	-84.92 %	-79.09 %
Quick Ratio TTM	0.03	0.03	0.03	0.04	0.05
Total Ranking TTM	#	#	#	#	#
Seq. Current Liabilities TTM Growth	1.38 %	4.69 %	-4.97 %	2.8 %	1.75 %
Seq. Cash & cash equivalent TTM Growth	3.9 %	7.42 %	-19.89 %	-22.18 %	9.89 %

Quick ratio ranking by company, industry and sector >> Back to LGYV Financial Strength Comparisons >> Go to Compare LGYV Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the drop in Current Liabilities in the Q2 2024 to $0.02 millions, cumulative Quick Ratio remained unchanged at 0.03 a new company low.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 193 other companies have achieved higher Quick Ratio than Legacy Ventures International Inc. While overall ranking is unchanged compared to the previous 12 months at no. 0.

Explain Quick Ratio?
How much Cash & cash equivalents LGYV�s has?
What are LGYV�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 194
Healthcare Sector	# 913
Within the Market	# 3960

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.04	0.11	0
(Jun 30 2022)		(Jun 30 2018)

Companies with similar Quick Ratio in the quarter ending Dec 31 2024, within Medical Equipment & Supplies Industry	Quick Ratio	Dec 31 2024 MRQ Cash & cash equivalent	Dec 31 2024 MRQ Current Liabilities
Dentsply Sirona Inc	0.17	$ 272.000 Millions	$ 1,589.000 Millions
Sharps Technology Inc	0.17	$ 0.864 Millions	$ 5.186 Millions
Zimmer Biomet Holdings Inc	0.17	$ 525.500 Millions	$ 3,157.400 Millions
National Vision Holdings Inc	0.16	$ 73.948 Millions	$ 468.274 Millions
Non Invasive Monitoring Systems Inc	0.16	$ 0.025 Millions	$ 0.161 Millions
Iridex Corp	0.14	$ 2.387 Millions	$ 16.559 Millions
Interpace Biosciences Inc	0.14	$ 1.461 Millions	$ 10.615 Millions
Stimcell Energetics Inc	0.14	$ 0.043 Millions	$ 0.317 Millions
Globus Medical Inc	0.12	$ 105.619 Millions	$ 855.913 Millions
The Cooper Companies Inc	0.12	$ 107.600 Millions	$ 892.900 Millions
Patterson Companies Inc	0.10	$ 134.996 Millions	$ 1,305.421 Millions
Baird Medical Investment Holdings Limited	0.09	$ 3.155 Millions	$ 34.185 Millions
Escalon Medical Corp	0.09	$ 0.209 Millions	$ 2.390 Millions
Dynatronics Corporation	0.09	$ 0.791 Millions	$ 9.210 Millions
Enovis Corp	0.08	$ 48.167 Millions	$ 582.365 Millions
Petvivo Holdings Inc	0.08	$ 0.115 Millions	$ 1.412 Millions
Medline Inc	0.08	$ 199.000 Millions	$ 2,527.000 Millions
Mountain Crest Acquisition Corp V	0.08	$ 0.117 Millions	$ 1.521 Millions
P3 Health Partners Inc	0.08	$ 38.816 Millions	$ 506.570 Millions
Positron Corporation	0.08	$ 0.070 Millions	$ 0.913 Millions
Qhslab Inc	0.07	$ 0.157 Millions	$ 2.407 Millions
Legacy Ventures International Inc	0.06	$ 0.001 Millions	$ 0.016 Millions
Streamex Corp	0.06	$ 0.142 Millions	$ 2.264 Millions
Boston Scientific Corporation	0.06	$ 414.000 Millions	$ 7,211.000 Millions
Biotricity Inc	0.05	$ 1.123 Millions	$ 23.419 Millions
Ss Innovations International Inc	0.05	$ 0.467 Millions	$ 9.843 Millions
Henry Schein Inc	0.04	$ 122.000 Millions	$ 2,728.000 Millions
Invo Fertility Inc	0.04	$ 0.741 Millions	$ 16.591 Millions
Regentis Biomaterials Ltd	0.04	$ 0.229 Millions	$ 5.507 Millions
Euda Health Holdings Limited	0.04	$ 0.238 Millions	$ 6.634 Millions

Date modified: 2025-06-23T22:38:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.